Survival and chemotherapy-related risk of second primary malignancy in breast cancer patients: a SEER-based study

ConclusionFemale breast cancer patients showed higher incidence of second primary malignancy, which was associated with poorer prognosis. Chemotherapy benefits should be weighed against the risks of second primary malignancy.
Source: International Journal of Clinical Oncology - Category: Cancer & Oncology Source Type: research